AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

IONIS PHARMACEUTICALS INC Director's Dealing 2020

Jan 3, 2020

30591_dirs_2020-01-03_45979ca9-36ff-4952-af27-55cab3e459ac.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2020-01-01

Reporting Person: Swayze Eric (SVP, Research)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	768	Direct